The COVID-19 pandemic led to significant changes in the way pharma engaged with healthcare practitioners (HCPs). To better understand these trends, ZoomRx analyzed over 20,000 sales rep interactions during the COVID-19 pandemic, uncovering unique insights on the impact of these rapidly changing sales models.
The following white paper examines how sales rep promotion has evolved over the course of the pandemic. Among the key findings are:
- The average impact of sales rep interactions on HCP prescribing has gradually declined over the course of the pandemic.
- In-person sales rep interactions, although still below pre-pandemic volumes, are currently more impactful than ever
- When well-coordinated, non-personal promotion (NPP) can enhance the impact of sales rep promotion by 25% or more.
In addition to analyzing the performance of promotional activity over the past year, the whitepaper presents strategies for increasing the impact of your promotional efforts moving forward, including how to successfully implement an omnichannel model of customer engagement.
Leave your information below to gain complimentary access to the white paper.
